19 February 2024
Addis Ababa, Ethiopia – The Africa Centres for Disease Control and Prevention (Africa CDC) announced progress in its initiative to boost domestic production of drugs and vaccines across the continent. This move aims to improve access to healthcare, save time and money, and enhance preparedness for future disease outbreaks.
Director General Jean Cassia highlighted the initiative’s impact on reducing reliance on tendering and procurement processes, leading to faster access to crucial medications.
The focus lies on tackling diseases like tuberculosis, cholera, Ebola, HIV/AIDS, and other communicable and non-communicable illnesses.
Africa CDC claims involvement in developing promising Ebola vaccine candidates, demonstrating commitment to proactive health protection.
Climate change-induced outbreaks like cholera are also being addressed through prevention efforts.
The organization seeks additional funding to further expand its production capabilities.
Established in 2016, Africa CDC plays a vital role in strengthening public health infrastructure and response mechanisms across African nations. This initiative signifies a crucial step towards self-reliance and improved healthcare accessibility for the continent
